Abstract
ABSTRACT In vivo passage of a poorly replicating, nonpathogenic simian-human immunodeficiency virus (SHIV-HXBc2) generated an efficiently replicating virus, KU-1, that caused rapid CD4 + T-lymphocyte depletion and AIDS-like illness in monkeys (S. V. Joag, Z. Li, L. Foresman, E. B. Stephens, L.-J. Zhao, I. Adany, D. M. Pinson, H. M. McClure, and O. Narayan, J. Virol. 70:3189–3197, 1996). The env gene of the KU-1 virus was used to create a molecularly cloned virus, SHIV-HXBc2P 3.2, that differed from a nonpathogenic SHIV-HXBc2 virus in only 12 envelope glycoprotein residues. SHIV-HXBc2P 3.2 replicated efficiently and caused rapid and persistent CD4 + T-lymphocyte depletion in inoculated rhesus macaques. Compared with the envelope glycoproteins of the parental SHIV-HXBc2, the SHIV-HXBc2P 3.2 envelope glycoproteins supported more efficient infection of rhesus monkey peripheral blood mononuclear cells. Both the parental SHIV-HXBc2 and the pathogenic SHIV-HXBc2P 3.2 used CXCR4 but none of the other seven transmembrane segment receptors tested as a second receptor. Compared with the parental virus, viruses with the SHIV-HXBc2P 3.2 envelope glycoproteins were more resistant to neutralization by soluble CD4 and antibodies. Thus, changes in the envelope glycoproteins account for the ability of the passaged virus to deplete CD4 + T lymphocytes rapidly and specify increased replicative capacity and resistance to neutralization.
Bibliography
Cayabyab, M., Karlsson, G. B., Etemad-Moghadam, B. A., Hofmann, W., Steenbeke, T., Halloran, M., Fanton, J. W., Axthelm, M. K., Letvin, N. L., & Sodroski, J. G. (1999). Changes in Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Responsible for the Pathogenicity of a Multiply Passaged Simian-Human Immunodeficiency Virus (SHIV-HXBc2). Journal of Virology, 73(2), 976â984.
Authors
10
- Mark Cayabyab (first)
- Gunilla B. Karlsson (additional)
- Bijan A. Etemad-Moghadam (additional)
- Wolfgang Hofmann (additional)
- Tavis Steenbeke (additional)
- Matilda Halloran (additional)
- John W. Fanton (additional)
- Michael K. Axthelm (additional)
- Norman L. Letvin (additional)
- Joseph G. Sodroski (additional)
References
55
Referenced
81
10.1126/science.272.5270.1955
10.1126/science.6189183
10.1038/382829a0
10.1073/pnas.94.5.1925
10.1128/jvi.69.1.166-171.1995
10.1126/science.7973652
10.1128/jvi.66.1.305-309.1992
10.1128/jvi.70.2.1301-1309.1996
10.1128/jvi.65.11.5782-5789.1991
10.1016/S0092-8674(00)81313-6
10.1126/science.2425430
- Cullen B. R. Use of eukaryotic expression technology in the functional analysis of clones genes.Methods Enzymol. 152 1989 64 73 / Methods Enzymol. / Use of eukaryotic expression technology in the functional analysis of clones genes by Cullen B. R. (1989)
10.1038/381661a0
10.1016/S0092-8674(00)81314-8
10.1038/381667a0
10.1084/jem.186.3.405
10.7326/0003-4819-100-1-92
10.1126/science.272.5263.872
10.1128/jvi.71.4.2779-2785.1997
10.1126/science.6200936
- Hayami M. and T. Igarashi. 1997. SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine. Leukemia 11 (Suppl. 3):95–97.
10.1128/jvi.64.5.2416-2420.1990
10.1038/373123a0
10.1128/jvi.70.5.3189-3197.1996
10.1128/jvi.71.6.4218-4225.1997
10.1128/jvi.68.4.2253-2259.1994
10.1016/0167-5699(90)90127-U
- Li J. Lord C. I. Haseltine W. Letvin N. L. Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins.J. Acquired Immune Defic. Syndr. 5 1992 639 646 / J. Acquired Immune Defic. Syndr. / Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins by Li J. (1992)
10.1128/jvi.69.11.7061-7067.1995
10.1084/jem.185.11.2015
10.1073/pnas.92.16.7490
10.1128/jvi.71.3.2522-2527.1997
10.1128/jvi.69.1.101-109.1995
10.1128/jvi.66.4.2067-2075.1992
10.1128/jvi.71.10.7518-7525.1997
10.1038/348069a0
10.1038/382833a0
10.1097/00002030-199702000-00006
- Posner M. R. Cavacini L. A. Emes C. L. Power J. Byrn R. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.J. Acquired Immune Defic. Syndr. 67 1993 7 14 / J. Acquired Immune Defic. Syndr. / Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120 by Posner M. R. (1993)
10.1128/jvi.70.10.6922-6928.1996
10.1128/jvi.70.5.3198-3206.1996
10.1002/cyto.990170113
10.1084/jem.182.1.185
10.1128/jvi.66.4.2588-2593.1992
10.1038/349167a0
10.1073/pnas.89.20.9434
10.1038/322470a0
10.1128/jvi.68.8.4973-4979.1994
10.1111/j.1600-0684.1996.tb00014.x
10.1006/viro.1997.8534
10.1128/JVI.72.8.6332-6338.1998
10.1128/jvi.69.7.4413-4422.1995
10.1128/jvi.68.2.674-680.1994
10.1128/jvi.66.9.5635-5641.1992
10.1073/pnas.88.8.3097
Dates
Type | When |
---|---|
Created | 5 years, 7 months ago (Dec. 31, 2019, 1:22 p.m.) |
Deposited | 3 years, 5 months ago (March 4, 2022, 10:29 p.m.) |
Indexed | 4 months, 3 weeks ago (April 8, 2025, 6:09 p.m.) |
Issued | 26 years, 6 months ago (Feb. 1, 1999) |
Published | 26 years, 6 months ago (Feb. 1, 1999) |
Published Print | 26 years, 6 months ago (Feb. 1, 1999) |
@article{Cayabyab_1999, title={Changes in Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Responsible for the Pathogenicity of a Multiply Passaged Simian-Human Immunodeficiency Virus (SHIV-HXBc2)}, volume={73}, ISSN={1098-5514}, url={http://dx.doi.org/10.1128/jvi.73.2.976-984.1999}, DOI={10.1128/jvi.73.2.976-984.1999}, number={2}, journal={Journal of Virology}, publisher={American Society for Microbiology}, author={Cayabyab, Mark and Karlsson, Gunilla B. and Etemad-Moghadam, Bijan A. and Hofmann, Wolfgang and Steenbeke, Tavis and Halloran, Matilda and Fanton, John W. and Axthelm, Michael K. and Letvin, Norman L. and Sodroski, Joseph G.}, year={1999}, month=feb, pages={976–984} }